NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	43,877	44,295	39,988	27,071	19,448	20,521
Other Revenue	24	24	32	14	14	40
Revenue	43,901	44,319	40,020	27,085	19,462	20,561
Revenue Growth (YoY)	-3.81%	10.74%	47.76%	39.17%	-5.34%	7.37%
Cost of Revenue	7,723	7,274	7,487	6,544	5,845	5,318
Gross Profit	36,178	37,045	32,533	20,541	13,617	15,243
Selling, General & Admin	6,749	5,991	5,309	4,625	4,806	4,390
Other Operating Expenses	11,993	9,029	9,599	6,072	5,952	4,634
Operating Expenses	21,306	17,383	16,827	12,443	12,383	10,310
Operating Income	14,872	19,662	15,706	8,098	1,234	4,933
Interest Expense	-240	-170	-120	-148	-132	-93
Interest & Investment Income	1,905	1,905	1,013	513	392	566
Currency Exchange Gain (Loss)	198	198	103	214	103	40
Other Non Operating Income (Expenses)	769	271	14	130	-3	30
EBT Excluding Unusual Items	17,504	21,866	16,716	8,807	1,594	5,476
Merger & Restructuring Charges	-	-	-	-291	-11	-
Gain (Loss) on Sale of Investments	14	14	-7	-52	12	-
Gain (Loss) on Sale of Assets	901	901	-17	178	427	320
Asset Writedown	-30	-30	-	-23	-	-
Pretax Income	18,552	22,914	16,735	8,619	2,022	5,796
Income Tax Expense	3,186	4,080	2,852	1,466	322	1,372
Earnings From Continuing Operations	15,366	18,834	13,883	7,153	1,700	4,424
Net Income to Company	15,366	18,834	13,883	7,153	1,700	4,424
Minority Interest in Earnings	21	20	-	-	-	-15
Net Income	15,387	18,854	13,883	7,153	1,700	4,409
Net Income to Common	15,387	18,854	13,883	7,153	1,700	4,409
Net Income Growth	-20.88%	35.81%	94.09%	320.76%	-61.44%	-4.32%
Shares Outstanding (Basic)	179	179	179	183	182	182
Shares Outstanding (Diluted)	179	179	179	183	182	182
Shares Change (YoY)	0.00%	-0.21%	-1.67%	0.08%	-0.04%	0.02%
EPS (Basic)	85.91	105.26	77.34	39.18	9.32	24.20
EPS (Diluted)	85.90	105.26	77.34	39.18	9.32	24.16
EPS Growth	-20.89%	36.10%	97.40%	320.39%	-61.42%	-4.35%
Free Cash Flow	13,379	12,957	8,722	7,028	-1,863	442
Free Cash Flow Per Share	74.69	72.34	48.59	38.50	-10.21	2.42
Dividend Per Share	5.000	6.000	9.500	5.500	4.500	5.250
Dividend Growth	-13.04%	-36.84%	72.73%	22.22%	-14.29%	-22.22%
Gross Margin	82.41%	83.59%	81.29%	75.84%	69.97%	74.13%
Operating Margin	33.88%	44.37%	39.25%	29.90%	6.34%	23.99%
Profit Margin	35.05%	42.54%	34.69%	26.41%	8.73%	21.44%
Free Cash Flow Margin	30.48%	29.24%	21.79%	25.95%	-9.57%	2.15%
EBITDA	16,853	21,442	17,506	9,669	2,600	6,066
EBITDA Margin	38.39%	48.38%	43.74%	35.70%	13.36%	29.50%
D&A For EBITDA	1,981	1,780	1,800	1,571	1,366	1,133
EBIT	14,872	19,662	15,706	8,098	1,234	4,933
EBIT Margin	33.88%	44.37%	39.25%	29.90%	6.34%	23.99%
Effective Tax Rate	17.17%	17.81%	17.04%	17.01%	15.93%	23.67%
Revenue as Reported	47,920	47,840	41,269	28,117	20,438	21,557
Advertising Expenses	-	-	-	-	326	211

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.